Curcumin as an effective suppressor of miRNA expression in patients with knee osteoarthritis

Objective: Osteoarthritis is the most common disease in the group of joint diseases, and its incidence is directly related to aging. Given the anti-inflammatory effects of curcumin as an active ingredient of turmeric, we aimed to investigate the effects of this compound in a new curcumin nanomicelle...

Full description

Saved in:
Bibliographic Details
Main Authors: Mahdi Atabaki (Author), Zhaleh Shariati-Sarabi (Author), Jalil Tavakkol-Afshari (Author), Ali Taghipour (Author), Mahmood Reza Jafari (Author), Amin Reza Nikpoor (Author), Mojgan Mohammadi (Author)
Format: Book
Published: Mashhad University of Medical Sciences, 2022-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c4d2b4f550c548f1bb21b14b11a1dc3b
042 |a dc 
100 1 0 |a Mahdi Atabaki  |e author 
700 1 0 |a Zhaleh Shariati-Sarabi  |e author 
700 1 0 |a Jalil Tavakkol-Afshari  |e author 
700 1 0 |a Ali Taghipour  |e author 
700 1 0 |a Mahmood Reza Jafari  |e author 
700 1 0 |a Amin Reza Nikpoor  |e author 
700 1 0 |a Mojgan Mohammadi  |e author 
245 0 0 |a Curcumin as an effective suppressor of miRNA expression in patients with knee osteoarthritis 
260 |b Mashhad University of Medical Sciences,   |c 2022-07-01T00:00:00Z. 
500 |a 2228-7930 
500 |a 2228-7949 
500 |a 10.22038/ajp.2021.19380 
520 |a Objective: Osteoarthritis is the most common disease in the group of joint diseases, and its incidence is directly related to aging. Given the anti-inflammatory effects of curcumin as an active ingredient of turmeric, we aimed to investigate the effects of this compound in a new curcumin nanomicelle formula named SinaCurcumin® on the expression of microRNAs (miRNAs) involved in immune responses of patients with osteoarthritis.Materials and Methods: We divided 30 patients with osteoarthritis into two groups namely, nano curcumin-receiving (15 patients) and placebo-receiving (15 patients) and we studied them for 3 months. The Iranian Registry of Clinical Trials (IRCT) approved our study with the IRCT registry No. IRCT20151028024760N4. We evaluated the rates of the expression of microRNAs 146, 155, 16, and 138 employing SYBR Green Real-Time PCR method.Results: The expression of miRNAs 155, 138, and 16 revealed a significant reduction in the curcumin-receiving group (p=0.002, p=0.024 and p=0.0001 respectively).Conclusion: Our research data indicated that the consumption of curcumin in patients with osteoarthritis could affect the immune system partially via altering the expression of microRNAs and cytokines. 
546 |a EN 
690 |a curcumin 
690 |a mir-146 
690 |a mir-15 
690 |a mir-138 
690 |a mir-16 
690 |a osteoarthritis 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Avicenna Journal of Phytomedicine, Vol 12, Iss 4, Pp 346-356 (2022) 
787 0 |n https://ajp.mums.ac.ir/article_19380_cda109064cd192c19b0e5317ebb155e2.pdf 
787 0 |n https://doaj.org/toc/2228-7930 
787 0 |n https://doaj.org/toc/2228-7949 
856 4 1 |u https://doaj.org/article/c4d2b4f550c548f1bb21b14b11a1dc3b  |z Connect to this object online.